| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2015083750 |
| Title |
Compound Pertaining To Neuropoiesis and Drug Composition. |
| Abstract |
Provided is a composition for activating neuropoiesis or neuron proliferation. In one or more embodiments, the composition contains, as the active ingredient, a compound having a DYRK inhibiting abili. |
| Applicant(s) |
Kyoto University |
| Representative Drug(s) |
D04SYJ |
Drug Info
|
IC50 = 7.94 nM |
[1] |
| Patent ID |
WO2011133795 |
| Title |
Beta-Carbolines As Inhibitors of Haspin and Dyrk Kinases. |
| Abstract |
The present disclosure is directed to compounds of Formula ( I ) which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Haspin kinase and DYRK kinase expression and/or activity. |
| Applicant(s) |
The Brigham and Women'S Hospital, Inc |
| Representative Drug(s) |
D02DBH |
Drug Info
|
N.A. |
[1] |
| Patent ID |
WO2011127406 |
| Title |
Acridines As Inhibitors of Haspin and Dyrk Kinases. |
| Abstract |
The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Haspin kinase and DYRK kinase expression and/or activity. |
| Applicant(s) |
The Brigham and Women'S Hospital, Inc |
| Representative Drug(s) |
D07BWC |
Drug Info
|
N.A. |
[1] |
